Product Information
BUDESONIDE DR 3 MG CAPSULE is a generic product labeled by American Health Packaging, priced at $0.4988 per EA under NDC 60687059632. Its NADAC has been published 277 times since May 5, 2021.
FDA first approved this application on May 4, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
3 mg/1
Manufacturer
American Health PackagingNDC
60687059632
Classification
Generic
Dosage Form
CAPSULE, COATED PELLETS
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
BUDESONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA206134FDA Approved
5/4/2017
TE Code
AB
On Market Since
3/9/2021
Pharmacological Classes
Price Statistics
The NADAC for BUDESONIDE DR 3 MG CAPSULE has been published 277 times since May 5, 2021, and over the history we have for it it has declined 48.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4988 per EA |
|---|---|
| All-time high | $1.0435 (Jan 12, 2022) |
| All-time low | $0.4242 (Nov 20, 2024) |
| 52-week high | $0.5230 |
| 52-week low | $0.4979 |
| Median price | $0.6302 |
| Average price | $0.6660 |
| Largest weekly change | +27.0% (Jun 19, 2024) |
| Weeks tracked | 277 |
| Tracking since | May 5, 2021 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BUDESONIDE DR 3 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE DR 3 MG CAPSULE, manufactured by American Health Packaging, is $0.4988 per EA (NDC 60687059632), effective Aug 19, 2026.
How has the price of BUDESONIDE DR 3 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for BUDESONIDE DR 3 MG CAPSULE has declined 48.9%. It has been tracked across 277 weekly CMS publications since May 5, 2021.
What are the highest and lowest recorded NADAC prices for BUDESONIDE DR 3 MG CAPSULE?
Since May 5, 2021, the NADAC for BUDESONIDE DR 3 MG CAPSULE has ranged from a low of $0.4242 (Nov 20, 2024) to a high of $1.0435 (Jan 12, 2022), with a median of $0.6302 per EA.
Are there cheaper alternatives to BUDESONIDE DR 3 MG CAPSULE?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as BUDESONIDE DR 3 MG CAPSULE in a comparable dosage form, but none are currently priced below it.
Who manufactures BUDESONIDE DR 3 MG CAPSULE?
BUDESONIDE DR 3 MG CAPSULE (NDC 60687059632) is labeled by American Health Packaging, and CMS classifies it as a generic product.